13 2.6 References

“ARDS Definition (Acute Respiratory Distress Syndrome).” YouTube, YouTube, 2 Oct. 2020, www.youtube.com/watch?v=K3GI8XHThaw.

“Biomarkers for ARDS: December 2019 Critical Care Medicine.” YouTube, YouTube, 21 Nov. 2019, https://www.youtube.com/watch?v=tVdxI53KR-w.

“COVID‐19 Acute Respiratory Distress Syndrome (ARDS): Clinical Features and Differences from Typical Pre‐COVID‐19 ARDS.” The Medical Journal of Australia, June 2020. PubMed Central, doi:10.5694/mja2.50674.

“Cytokine Storm and Use of Anakinra in a Patient with COVID-19.” BMJ Case Reports CP, vol. 13, no. 9, BMJ Specialist Journals, Sept. 2020, p. e237525. casereports.bmj.com, doi:10.1136/bcr-2020-237525.

“Neutrophils: Their Role in Innate and Adaptive Immunity.” Journal of Immunology Research, vol. 2016, 2016. PubMed Central, doi:10.1155/2016/1469780.

Acosta, Manuel A. Torres, and Benjamin D. Singer. “Pathogenesis of COVID-19-Induced ARDS: Implications for an Ageing Population.” European Respiratory Journal, vol. 56, no. 3, 2020, p. 2002049., doi:10.1183/13993003.02049-2020.

Acosta, Manuel A. Torres, and Benjamin D. Singer. “Pathogenesis of COVID-19-Induced ARDS: Implications for an Aging Population.” European Respiratory Journal, European Respiratory Society, Jan. 2020. erj.ersjournals.com, doi:10.1183/13993003.02049-2020.

Adapted from “Flow chart 1 (2 groups, vertical)”, by BioRender.com (2020). Retrieved from https://app.biorender.com/biorender-templates.

Adapted from “Lungs (healthy vs. diseased)”, by BioRender.com (2020). Retrieved from https://app.biorender.com/biorender-templates.

Calfee, Carolyn S., et al. “Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.” The Lancet Respiratory Medicine, vol. 2, no. 8, 2014, pp. 611-620., https://doi.org/10.1016/S2213-2600(14)70097-9.

Chang, Hsu-Liang, et al. “Acute Respiratory Distress Syndrome and Acute Myocarditis Developed in a Previously Healthy Adult with Influenza B.” BMC Pulmonary Medicine, vol. 16, no. 1, 2016, doi:10.1186/s12890-015-0163-3.

Derwall, Matthias, Lukas Martin, and Rolf Rossaint. “The acute respiratory distress syndrome: pathophysiology, current clinical practice, and emerging therapies.” Expert review of respiratory medicine, vol. 12, no. 12, 2018, pp. 1021-1029., https://doi.org/10.1080/17476348.2018.1548280.

Diamond, Matthew, et al. “Acute Respiratory Distress Syndrome.” StatPearls, StatPearls Publishing, 18 November 2020.

Eberl, Matthias. “Neutrophils.” British Society for Immunology, www.immunology.org/public-information/bitesized-immunology/cells/neutrophils.

Ernani, Vinicius, Conor E. Steuer, and Mohammad Jahanzeb. “The end of nihilism: systemic therapy of advanced non–small cell lung cancer.” Annual review of medicine, vol 68, 2017, pp. 153-168., https://doi.org/10.1146/annurev-med-042915-102442.

Giamarellos-Bourboulis, Evangelos J., et al. “Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.” Cell Host & Microbe, vol. 27, no. 6, 2020, doi:10.1016/j.chom.2020.04.009.

Gibson, Peter G., et al. “COVID‐19 Acute Respiratory Distress Syndrome (ARDS): Clinical Features and Differences from Typical Pre‐COVID‐19 ARDS.” The Medical Journal of Australia, June 2020. PubMed Central, doi:10.5694/mja2.50674.

Horie, Shahd, et al. “Emerging pharmacological therapies for ARDS: COVID-19 and beyond.” Intensive care medicine, vol. 46, no. 12, 2020, pp. 2265-2283., https://doi.org/10.1007/s00134-020-06141-z.

Kobayashi, Scott D., et al. “Neutrophils in the Innate Immune Response.” Arch Immunol Ther Exp, 2005, p. 13.

Lawler, Patrick R., and Eddy Fan. “Heterogeneity and phenotypic stratification in acute respiratory distress syndrome.” The Lancet Respiratory Medicine, vol. 6, no. 9, 2018, pp. 651-653., https://doi.org/10.1016/S2213-2600(18)30287-X.

Matthay, Michael A., et al. “Acute Respiratory Distress Syndrome.” Nature Reviews Disease Primers, vol. 5, no. 1, 2019, doi:10.1038/s41572-019-0069-0.

Nemchand, Priyanka, et al. “Cytokine Storm and Use of Anakinra in a Patient with COVID-19.” BMJ Case Reports, vol. 13, no. 9, Sept. 2020, p. e237525. DOI.org (Crossref), doi:10.1136/bcr-2020-237525.

Oldham, Kim. “Chemokines: Introduction.” British Society for Immunology, www.immunology.org/public-information/bitesized-immunology/receptors-and-molecules/chemokines-introduction.

Perl, Mario, et al. “Pathogenesis of Indirect (Secondary) Acute Lung Injury.” Expert Review of Respiratory Medicine, vol. 5, no. 1, 2011, pp. 115–126., doi:10.1586/ers.10.92.

Petri, Björn, and Maria-Jesús Sanz. “Neutrophil Chemotaxis.” Cell and Tissue Research, vol. 371, no. 3, Mar. 2018, pp. 425–36. Springer Link, doi:10.1007/s00441-017-2776-8.

Puneet, Padmam, et al. “Chemokines in Acute Respiratory Distress Syndrome.” American Journal of Physiology – Lung Cellular and Molecular Physiology, vol. 288, no. 1, Jan. 2005, pp. L3–15. PubMed Central, doi:10.1152/ajplung.00405.2003.

Rosales, Carlos, et al. “Neutrophils: Their Role in Innate and Adaptive Immunity.” Journal of Immunology Research, vol. 2016, 2016. PubMed Central, doi:10.1155/2016/1469780.

Selders, Gretchen et al. “An overview of the role of neutrophils in innate immunity, inflammation and host bio-material integration.” Regenerative Biomaterials, Oct. 2016, pp. 55-68. doi: 10.1093/rb/rbw041.

Shankar-Hari, Manu, and Daniel F. McAuley. “Acute respiratory distress syndrome phenotypes and identifying treatable traits. The dawn of personalized medicine for ARDS.” American Journal of Respiratory and Critical Care Medicine, vol. 195, no. 3, 2017, pp. 280-281.

Shaw, Timothy D., Daniel F. McAuley, and Cecilia M. O’Kane. “Emerging drugs for treating the acute respiratory distress syndrome.” Expert Opinion on Emerging Drugs, vol. 24, no. 1, 2019, pp. 29-41., https://doi.org/10.1080/14728214.2019.1591369

Torres Acosta, Manuel A., and Benjamin D. Singer. “Pathogenesis of COVID-19-Induced ARDS: Implications for an Ageing Population.” European Respiratory Journal, vol. 56, no. 3, Sept. 2020, p. 2002049. DOI.org (Crossref), doi:10.1183/13993003.02049-2020.

Vassiliou, Alice G., et al. “Endothelial Damage in Acute Respiratory Distress Syndrome.” International Journal of Molecular Sciences, vol. 21, no. 22, 2020, p. 8793., doi:10.3390/ijms21228793.

Ventilator/Ventilator Support. www.nhlbi.nih.gov/health-topics/ventilatorventilator-support.

Williams, Andrew E, et al. “Evidence for Chemokine Synergy during Neutrophil Migration in ARDS.” Thorax, vol. 72, no. 1, 2016, pp. 66–73., doi:10.1136/thoraxjnl-2016-208597.

Zemans, Rachel L, and Matthay, Michael A. “What Drives neutrophils to the alveoli in ARDS?” Thorax, Oct. 2016. doi: 10.1136/thoraxjnl-2016-209170

Zompatori, Maurizio, et al. “Overview of Current Lung Imaging in Acute Respiratory Distress Syndrome.” European Respiratory Review, vol. 23, no. 134, 2014, pp. 519–530., doi:10.1183/09059180.00001314.